Lyell Immunopharma to Participate in BofA Securities Health Care Conference [Yahoo! Finance]
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
Lyell Immunopharma, Inc. (NASDAQ: LYEL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024 [Yahoo! Finance]
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024